Bath & Body Works Faces Securities Fraud Lawsuit
Investors in Bath & Body Works, Inc. are being reminded of an opportunity to lead a securities fraud lawsuit against the company. The suit covers a period from June 2024 to November 2025, with the Rosen Law Firm alleging the company may have issued misleading business information to investors.
The lawsuit alleges that Bath & Body Works' strategy of expanding into new product areas like men's grooming, hair care, and laundry—termed "adjacencies"—was not attracting new customers or generating the sales growth the company claimed. Instead, the company allegedly relied on brand collaborations to mask weak underlying financial performance. Triggering events for the lawsuit include the company's second-quarter 2025 financial results, which showed a 55.8% year-over-year drop in earnings per diluted share. This was followed by third-quarter results revealing a significant revenue decline and a cut in net sales guidance. Following the third-quarter announcements on November 20, 2025, Bath & Body Works' stock price plummeted by $5.22 per share, a 24.8% drop, closing at $15.82. This significant decline in market value is a key component of the damages investors claim to have suffered. In response to these results, the company acknowledged that its focus on "adjacencies" had "not grown our total customer base" and had pulled focus from its core product categories. As a result, Bath & Body Works announced it would be exiting some of these new product areas. Multiple law firms, including Rosen Law Firm, Kessler Topaz Meltzer & Check, and Glancy Prongay & Murray, have filed class-action lawsuits on behalf of investors. The lead plaintiff deadline for investors to join the lawsuit is March 16, 2026.
